United States· US:55111-532_a886188f-930f-fcf2-d361-a2a608f95154
Divalproex sodium
A medicinal product containing divalproex sodium, registered in United States by Dr. Reddy's Laboratories Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Divalproex sodium
- Manufacturer
- Dr. Reddy's Laboratories Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 4
- ndc115511153201100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-01)
- ndc115511153205500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-05)
- ndc11551115323030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-30)
- ndc11551115327810 BLISTER PACK in 1 CARTON (55111-532-78) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (55111-532-79)
Regulatory notes
Same medicine, other countries
Divalproex sodium in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- France · Depakote, Divalcote
- United Kingdom (Northern Ireland) · Belvo, Depakote
- Croatia · Dipleksil
- Portugal · Diplexil-R, Valproato Semisódico Tecnifar
- Slovenia · Dipleksil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e563cd4e-833e-4d3c-b9a3-f5e722b724b7 GET /v1/drugs/e563cd4e-833e-4d3c-b9a3-f5e722b724b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "644VL95AO6",
"rxcui": "266856",
"inchikey": "MSRILKIQRXUYCT-UHFFFAOYSA-M",
"display_name": "DIVALPROEX SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"773a289b-65ed-4045-80c5-f00e28c1c079": {
"match": "brand_token",
"title": "DIVALPROEX SODIUM CAPSULE, COATED PELLETS [AJANTA PHARMA USA INC.]",
"spl_version": "14",
"published_date": "2026-06-01"
}
},
"productid": "55111-532_a886188f-930f-fcf2-d361-a2a608f95154",
"productndc": "55111-532",
"dosage_form": "CAPSULE, DELAYED RELEASE",
"orange_book": {
"appl_no": "078979",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 125MG VALPROIC ACID",
"product_no": "001",
"approval_date": "Jan 23, 2009"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DIVALPROEX SODIUM",
"proprietary_name": "Divalproex sodium",
"active_ingred_unit": "mg/1",
"application_number": "ANDA078979",
"marketing_category": "ANDA",
"nonproprietary_name": "Divalproex sodium",
"start_marketing_date": "20090123",
"active_numerator_strength": "125"
}See everything about divalproex sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.